Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

Condensed Balance Sheet
Sep. 30, 2020
USD ($)
Current assets:  
Prepaid expenses $ 4,967
Total current assets 4,967
Deferred offering costs associated with initial public offering 495,755
Total assets 500,722
Current liabilities:  
Accounts payable 30,255
Accrued expenses 259,000
Note payable - related party 206,500
Total current liabilities 495,755
Commitments and Contingencies
Shareholders' Equity  
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 24,066
Accumulated deficit (20,033)
Total shareholders' equity 4,967
Total Liabilities and Shareholders' Equity 500,722
Common Class A [Member]  
Shareholders' Equity  
Common Stock, Value, Issued
Common Class B [Member]  
Shareholders' Equity  
Common Stock, Value, Issued $ 934 [1],[2]
[1] Shares and the associated amounts have been retroactively restated to reflect the surrender of 3,593,750 founder shares to the company for no consideration on October 15, 2020; resulting in a decrease in the total number of Class B ordinary shares outstanding to 9,343,750 shares (see Note 4).
[2] This number includes up to 1,218,750 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On December 1, 2020, the underwriters partially exercised the over-allotment option to purchase an additional of 3,894,500 Units; thus, only 245,125 shares of Class B ordinary shares remain subject to forfeiture.